Track the 株式会社コスモス薬品 share price and the full directors' dealings record of the company, a publicly traded company based in Japan. Shares trade on the JP market, under the oversight of EDINET (Japan FSA). Operating in the Retail sector, 株式会社コスモス薬品 has published 8 public disclosures. Market capitalisation: €494.2bn. The latest transaction was reported on 5 March 2025 (Holding update). Among the most active insiders: JPMorgan Asset Management (Japan) Limited. Every trade is free.
Analysts rate 株式会社コスモス薬品 Buy (bullish), based on 10 analysts. Average price target: JP¥7,571.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
8 of 8 declarations
Cosmos Pharmaceutical Corporation es una empresa japonesa especializada en la distribución de productos farmacéuticos y bienes de consumo. Opera principalmente en el mercado farmacéutico y minorista en Japón.